Kuehn Law's investigation into Globus Medical raises potential shareholder litigation risk for the medical device firm
Executive summary: Kuehn Law encouraged investors of Globus Medical, Inc. (NYSE: GMED) to contact the firm as it investigates possible fiduciary duty breaches by certain officers and directors. A successful shareholder lawsuit could trigger significant legal costs, potential settlements, and heightened investor scrutiny of Globus Medical’s governance, impacting its market valuation.
Who is involved: Kuehn Law PLLC, Globus Medical Inc. officers and directors, and the company’s shareholders/investors.
Likely next: Further fact‑finding by Kuehn Law, possible filing of a securities class action complaint by late September 2026, and potential SEC or Delaware court oversight of the matter.
Kuehn Law, PLLC announced it is examining whether certain officers and directors of Globus Medical, Inc. violated fiduciary duties to shareholders, urging investors to contact the firm. The probe centers on alleged self‑dealing transactions that, if substantiated, could expose the company to costly securities class actions and regulatory scrutiny. Such litigation could affect Globus Medical’s stock price, increase legal expenses, and draw attention to governance practices across the medical device sector.
Timeline
- — BMI Deadline: BMI Investors Have Opportunity to Lead Badger Meter, Inc. Securities Fraud Lawsuit (PR Newswire)
- — EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit (PR Newswire)
- — Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm (PR Newswire)
Analysis — what this means
Likely next events
- Investors may contact Kuehn Law by mid‑August 2026 to join the investigation
- If sufficient claims are gathered, a class action complaint could be filed by September 30, 2026
- Globus Medical may appoint a special committee or issue a public response by mid‑August 2026
Sectors affected
- Medical devices (spinal implants)
- Healthcare equity markets
- Shareholder litigation services
Regulatory implications
- Potential SEC investigation under Section 10(b) of the Securities Exchange Act
- Possible enforcement of fiduciary duty standards under Delaware General Corporation Law
- Increased scrutiny of related‑party transactions in the medical device sector
Sources
- Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm — PR Newswire
- BMI Deadline: BMI Investors Have Opportunity to Lead Badger Meter, Inc. Securities Fraud Lawsuit — PR Newswire
- EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit — PR Newswire
Related cases
- Kuehn Law is probing Immunovant’s officers for possible fiduciary breaches, raising litigation and governance concerns
- Kuehn Law probes Exelixis executives for possible self‑dealing, inviting shareholder contact
- Kuehn Law launches fiduciary duty probe into CG Oncology, urging shareholders to come forward
- Kuehn Law is investigating Arcus Biosciences officers for possible fiduciary duty breaches
- Kuehn Law’s probe into Flowco Holdings raises self‑dealing concerns, highlighting potential legal exposure for the firm
- Kuehn Law's investigation into Travere Therapeutics raises potential governance concerns for the biotech firm's shareholders